Novartis Fights Actavis' Generic Dementia Patch
Pharmaceutical giant Novartis Pharmaceuticals Corp. lodged a patent infringement suit in Delaware on Thursday, seeking to stop Actavis Inc. from marketing a generic form of Novartis' Exelon patch used to treat...To view the full article, register now.
Already a subscriber? Click here to view full article